Sign In
Buy PODD
$143.30
+0.87 (+0.611%)
At Close: Jun 03, 2026
Insulet to Present at the Goldman Sachs 46th Annual Global Healthcare Conference 2025
06:01am, Friday, 23'rd May 2025
ACTON, Mass.--(BUSINESS WIRE)--Insulet Corporation (NASDAQ: PODD) (Insulet), the global leader in tubeless insulin pump technology with its Omnipod® brand of products, today announced that management
4 Medical Product Stocks to Watch From a Challenging Industry
12:41pm, Wednesday, 21'st May 2025
The U.S. government's tariff imposition, especially on China, is likely to keep supply chains under pressure for the Zacks Medical Products industry. PODD, MGNX, CLRB and ALUR reflect the favorable fu
Here's Why Insulet (PODD) is a Strong Momentum Stock
10:56am, Friday, 16'th May 2025
Wondering how to pick strong, market-beating stocks for your investment portfolio? Look no further than the Zacks Style Scores.
Why Insulet (PODD) is a Top Growth Stock for the Long-Term
10:50am, Thursday, 15'th May 2025
Wondering how to pick strong, market-beating stocks for your investment portfolio? Look no further than the Zacks Style Scores.
Insulet Surges on Q1 Beat, Emerges as a Top S&P 500 Performer
08:46am, Wednesday, 14'th May 2025
Insulet Corporation's NASDAQ: PODD recent outperformance has caught investors' attention and has earned it a designation as a top performer on the S&P 500.
Outlier Money Flows Lift Insulet
07:20am, Wednesday, 14'th May 2025
Big Money buying shares of Insulet Corporation (PODD).
Insulet Announces Publication of 2024 Sustainability Report
06:00am, Tuesday, 13'th May 2025
ACTON, Mass.--(BUSINESS WIRE)--Insulet Corporation (NASDAQ: PODD) (Insulet or the Company), the global leader in tubeless insulin pump technology with its Omnipod® brand of products, is proud to anno
Insulet Q1 Earnings Top Estimates, Stock Up, 2025 Sales View Raised
10:10am, Monday, 12'th May 2025
PODD delivers better-than-expected earnings and revenues in the first quarter of 2025.
S&P 500 Giants Visa, Insulet Lead 5 Stocks Near Buy Points
11:47am, Saturday, 10'th May 2025
Visa has topped a buy point, while fellow S&P 500 component Insulet gapped out of a base, leading five stocks on this weekend watchlist.
S&P 500 Gains & Losses Today: Index Pulls Back Early Climb Amid Anticipation of Trade Talks
06:31pm, Friday, 09'th May 2025
Major U.S. equities indexes pulled back from their early gains Friday as investors wait for new developments on tariffs ahead of a weekend meeting between U.S. and Chinese officials.
Insulet Stock Soars To A High After Robust Earnings; This Customer Management Name Pops
04:02pm, Friday, 09'th May 2025
Insulet stock soared after the company topped first quarter earnings and sales estimates. And a customer management stock hit a new high.
Top Stock Movers Now: Tesla, Monster Beverage, Insulet, and More
12:31pm, Friday, 09'th May 2025
U.S. equities were mixed and little changed at midday as the markets awaited key trade talks between the U.S. and China set for this weekend. The Dow Jones Industrial Average edged lower, while the S&
Insulet Posts Strong Q1 Results, Raises Forecasts On Momentum In US And Abroad
11:05am, Friday, 09'th May 2025
Insulet Corporation PODD reported first-quarter adjusted earnings of $1.02 per share, beating the consensus of 80 cents.
Insulet Is the Top S&P 500 Performer Today. Here's Why.
10:11am, Friday, 09'th May 2025
The insulin pump maker beat earnings expectations for the first quarter and raised its forecast for 2025.
Insulet Corporation (PODD) Q1 2025 Earnings Call Transcript
10:35pm, Thursday, 08'th May 2025
Insulet Corporation (NASDAQ:PODD ) Q1 2025 Earnings Conference Call May 8, 2025 4:30 PM ET Company Participants June Lazaroff - Senior Director, IR Tim Scannell - Chair Ashley McEvoy - President and C
